pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
MVCCOV-1901
Coronavirus Disease 2019 (COVID-19)
Medigen Vaccine Biologics Corp
0
catalysts
Phase 2
MVRT-3011
Recurrent Head And Neck Squamous Cell Carcinoma
Immvira Co Ltd
0
catalysts
Phase 2
MVX-220
Angelman Syndrome
Mavrix Bio LLC
0
catalysts
Phase 2
MWTx-01
Polycythemia Vera
Disc Medicine, Inc.
← prev
page 19 of 50
next →
131
Pain
89
Neurology
1
$IRON
0
catalysts
Phase 2
MZ-1866
Unspecified Genetic Disorders
Mahzi Therapeutics Inc
0
catalysts
Phase 2
MaaT-013
Graft Versus Host Disease (GVHD)
MaaT Pharma SA
0
catalysts
Phase 2
MesenCure
Acute Respiratory Distress Syndrome
Bonus BioGroup Ltd
0
catalysts
Phase 2
MesoCancerVac
MesoPher
Malignant Mesothelioma
Amphera BV
0
catalysts
Phase 2
Motrem
Septic Shock
Triggering receptor expressed on myeloid cells 1
Inotrem SA
0
catalysts
Phase 2
Mydicar
Systolic Heart Failure (HFrEF)
Sardocor Corp
0
catalysts
Phase 2
N-acetyl cysteine amide
Retinitis Pigmentosa (Retinitis)
Nacuity Pharmaceuticals Inc
0
catalysts
Phase 2
NA-704
Amyotrophic Lateral Sclerosis
Biomed Industries Inc
0
catalysts
Phase 2
NA-931
Obesity
Biomed Industries Inc
0
catalysts
Phase 2
NB-001
DiGeorge Syndrome
Nobias Therapeutics Inc
0
catalysts
Phase 2
NB-003
Gastrointestinal Stromal Tumor (GIST)
NewBay Medical Technology Co Ltd
0
catalysts
Phase 2
NBM-BMX
Metastatic Uveal Melanoma
Novelwise Pharmaceutical Corp
0
catalysts
Phase 2
NC-410
Cervical Cancer
$NXTC
NextCure, Inc.
0
catalysts
Phase 2
NCS-01
Acute Ischemic Stroke
NC Medical Research Inc
0
catalysts
Phase 2
ND-10 ER
Myopia
Theialife Sciences Pvt Ltd
0
catalysts
Phase 2
NEO-100
Recurrent Glioblastoma Multiforme (GBM)
$NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
0
catalysts
Phase 2
NEO-212
Astrocytoma
$NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
0
catalysts
Phase 2
NG-350A
Epithelial Tumor
Akamis Bio Ltd
0
catalysts
Phase 2
NGGT-002
Phenylketonuria (PKU)
Next Generation Gene Therapeutics Inc
0
catalysts
Phase 2
NOUS-209
Gastric Cancer
Nouscom AG
0
catalysts
Phase 2
NP-213
Novexatin
Onychomycosis (Tinea Unguium)
Novabiotics Ltd
0
catalysts
Phase 2
NRT-023
Post Partum Depression (Maternal Depression / Postnatal Depression)
Nanjing Noratech Pharmaceutical Inc
0
catalysts
Phase 2
NS-050
Duchenne Muscular Dystrophy
NS Pharma Inc
0
catalysts
Phase 2
NS-229
Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)
Nippon Shinyaku Co Ltd
0
catalysts
Phase 2
NT-101
Wet (Neovascular / Exudative) Macular Degeneration
NexThera Co Ltd
0
catalysts
Phase 2
NT-219
Metastatic Colorectal Cancer
$PPBT
PURPLE BIOTECH LTD.
0
catalysts
